UK orders new monitoring and revision regime for all MoM hips
This article was originally published in RAJ Devices
The UK Medicines and Healthcare products Regulatory Agency has issued a device alert requiring that all patients with metal-on-metal (MoM) hip replacements undergo a tighter follow-up regime1.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.